Stock movement: Invacare, ResMed
InvacareCFO Robert Gudbranson bought 4,200 company shares at an average price of $12.01 per share in a transaction on Feb. 29 worth $50,442. He now owns 101,821 shares worth about $1.2 million. Additionally, Invacare Vice President Anthony Laplaca bought 1,000 company shares at an average price of $12.38 per share in a transaction on Feb. 29 worth about $12,400. Invacare announced in February that it is preparing to submit a final report to lift its consent decree with the Food and Drug Administration…ResMed CFO Brett Sandercock sold 30,000 company shares for an average of $57.61 per share in a transaction on Feb. 26 worth about $1.7 million. He now has 132,136 shares worth about $7.6 million. Janus Capital Management increased its number of shares in ResMed by 345,234 in the third quarter for a total of 494,328 shares. It now has a $25.2 million stake in the company. ResMed has made headlines recently by buying Brightree and Inova Technologies.